TP53 and breast cancer: The H19/p53/TNFAIP8 axis promoted a series of tumor cell activities including proliferation, migration, invasion, EMT and metastasis both in vitro and in vivo, whereas silencing of lncRNA H19 exerted suppressive effects on these cell activities in breast cancer.